Golimumab Intravenous Infusion Registry (GO-IV)

Trial Profile

Golimumab Intravenous Infusion Registry (GO-IV)

Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Golimumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms GO-IV
  • Sponsors Janssen
  • Most Recent Events

    • 08 Nov 2017 Results assessing infusion reactions presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 26 Oct 2016 Status changed from recruiting to discontinued due to business decision based on lack of enrollment.
    • 19 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top